Kenya to study COVID-19 blood plasma treatment

Kenya is developing a protocol that will allow experts to explore treatment of moderately ill COVID-19 patients with blood plasma from recovered patients.

COVID-19 survivors are left with blood plasma, the liquid portion of the blood that contains antibodies used to help fight infection.

The health ministry’s chief administrative secretary, Mercy Mwangangi, disclosed that under the study, experts will explore the possibility of taking the blood of someone who has recovered from COVID-19 and to use it as medicine for those who have moderate illness.

Globally, there are more than 80 trials recruiting COVID-19 patients to study the effect of convalescent plasma – blood from recovered patients.

South Africa is also testing this therapy.